Coagulation factor activator from snake venom (null)

Coagulation factor activators from snake venom are a diverse group of enzymes and protein complexes that directly or indirectly activate blood coagulation factors, notably prothrombin and factor X, often bypassing the normal regulatory cascade. These molecules are mainly serine proteases (from elapid venoms) and metalloproteases (from viperid venoms), with some requiring non-enzymatic C-type lectin-related protein cofactors to confer substrate specificity or regulatory effects. They convert prothrombin into active thrombin or intermediate meizothrombin, facilitating rapid fibrin clot formation or, paradoxically, disrupting normal coagulation to cause bleeding or anticoagulation effects. These molecules have been isolated and characterized from multiple medically important snake species, and individual enzymes (e.g., Ecarin, Textarin, Trocarin) are used in diagnostic testing for coagulation disorders and as research tools for drug development. While these activators have inspired therapeutic research, most clinical applications are limited to diagnostic or experimental contexts due to safety and specificity challenges.

Other names

Snake venom procoagulant enzymeSnake venom prothrombin activatorThrombin-like enzyme from snake venomFactor X activator from snake venomSerine protease (snake venom, procoagulant)Snake venom metalloprotease (procoagulant)EcarinTextarinTrocarin

Direct activation of prothrombin to thrombin or intermediate meizothrombin, bypassing physiological coagulation factor cascades. Fibrinogen degradation (thrombin-like cleavage). Interference with clotting factor binding (via C-type lectin-related domains). Modification of platelet function and blood vessel response